Titre : Capacité vitale

Capacité vitale : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment évaluer la capacité vitale ?

La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire.
Spirométrie Fonction pulmonaire
#2

Quels tests complètent l'évaluation ?

Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés.
Pléthysmographie Gaz du sang
#3

Quels sont les critères normaux de capacité vitale ?

Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L.
Capacité vitale Normes physiologiques
#4

Quand suspecter une capacité vitale réduite ?

Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires.
Dyspnée Maladies pulmonaires
#5

Quels signes indiquent un problème pulmonaire ?

Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée.
Toux Fatigue

Symptômes 5

#1

Quels symptômes sont liés à une capacité vitale faible ?

Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique.
Essoufflement Oppression thoracique
#2

La toux est-elle un symptôme associé ?

Oui, une toux persistante peut accompagner une capacité vitale diminuée.
Toux Capacité vitale
#3

Comment la fatigue se manifeste-t-elle ?

La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort.
Fatigue Effort physique
#4

Y a-t-il des signes d'alerte ?

Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate.
Douleurs thoraciques Cyanose
#5

Les symptômes varient-ils selon l'âge ?

Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire.
Âge Dégradation pulmonaire

Prévention 5

#1

Comment prévenir la réduction de la capacité vitale ?

Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée.
Tabagisme Activité physique
#2

Les vaccinations sont-elles importantes ?

Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires.
Vaccins Infections respiratoires
#3

Quel rôle joue l'exercice physique ?

L'exercice régulier améliore la fonction pulmonaire et la capacité vitale.
Exercice physique Fonction pulmonaire
#4

Faut-il éviter certaines expositions ?

Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire.
Polluants Allergènes
#5

L'hydratation est-elle importante ?

Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires.
Hydratation Voies respiratoires

Traitements 5

#1

Quels traitements améliorent la capacité vitale ?

Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes.
Réhabilitation pulmonaire Bronchodilatateurs
#2

La physiothérapie est-elle utile ?

Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire.
Physiothérapie Fonction pulmonaire
#3

Les médicaments peuvent-ils aider ?

Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires.
Médicaments Bronchodilatateurs
#4

Quand envisager une intervention chirurgicale ?

Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO.
Chirurgie BPCO
#5

Les traitements varient-ils selon la cause ?

Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale.
Causes Traitement

Complications 5

#1

Quelles complications peuvent survenir ?

Des complications incluent l'insuffisance respiratoire et des infections pulmonaires.
Insuffisance respiratoire Infections pulmonaires
#2

La capacité vitale faible augmente-t-elle les risques ?

Oui, une capacité vitale faible augmente le risque de complications respiratoires graves.
Capacité vitale Complications respiratoires
#3

Les maladies cardiaques sont-elles liées ?

Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques.
Maladies cardiaques Capacité vitale
#4

Comment les infections affectent-elles la capacité vitale ?

Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation.
Infections pulmonaires Inflammation
#5

Y a-t-il des effets à long terme ?

Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire.
Effets à long terme Santé respiratoire

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux.
Tabagisme Polluants
#2

L'âge influence-t-il la capacité vitale ?

Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire.
Âge Dégradation pulmonaire
#3

Les maladies chroniques sont-elles un facteur ?

Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite.
Asthme BPCO
#4

Le sexe joue-t-il un rôle ?

Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne.
Sexe Capacité vitale
#5

L'environnement de travail est-il un facteur ?

Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale.
Environnement de travail Pollution
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Capacité vitale : Questions médicales les plus fréquentes", "headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-22", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Capacité vitale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Capacité pulmonaire totale", "url": "https://questionsmedicales.fr/mesh/D014109", "about": { "@type": "MedicalCondition", "name": "Capacité pulmonaire totale", "code": { "@type": "MedicalCode", "code": "D014109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve expiratoire", "alternateName": "Expiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D005105", "about": { "@type": "MedicalCondition", "name": "Volume de réserve expiratoire", "code": { "@type": "MedicalCode", "code": "D005105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.360" } } }, { "@type": "MedicalWebPage", "name": "Capacité inspiratoire", "alternateName": "Inspiratory Capacity", "url": "https://questionsmedicales.fr/mesh/D007320", "about": { "@type": "MedicalCondition", "name": "Capacité inspiratoire", "code": { "@type": "MedicalCode", "code": "D007320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve inspiratoire", "alternateName": "Inspiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D007321", "about": { "@type": "MedicalCondition", "name": "Volume de réserve inspiratoire", "code": { "@type": "MedicalCode", "code": "D007321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.375" } } }, { "@type": "MedicalWebPage", "name": "Volume courant", "alternateName": "Tidal Volume", "url": "https://questionsmedicales.fr/mesh/D013990", "about": { "@type": "MedicalCondition", "name": "Volume courant", "code": { "@type": "MedicalCode", "code": "D013990", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.700" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Capacité vitale", "alternateName": "Vital Capacity", "code": { "@type": "MedicalCode", "code": "D014797", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Toby M Maher", "url": "https://questionsmedicales.fr/author/Toby%20M%20Maher", "affiliation": { "@type": "Organization", "name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA." } }, { "@type": "Person", "name": "Hyun Lee", "url": "https://questionsmedicales.fr/author/Hyun%20Lee", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Hye Yun Park", "url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Masato Kono", "url": "https://questionsmedicales.fr/author/Masato%20Kono", "affiliation": { "@type": "Organization", "name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/37000790", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0283110" } }, { "@type": "ScholarlyArticle", "name": "Lung and chest wall volume during vital capacity manoeuvre in Osteogenesis Imperfecta.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36307878", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13023-022-02535-y" } }, { "@type": "ScholarlyArticle", "name": "Body Mass Index is Associated with blood pressure and vital capacity in medical students.", "datePublished": "2023-10-18", "url": "https://questionsmedicales.fr/article/37853414", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12944-023-01920-1" } }, { "@type": "ScholarlyArticle", "name": "Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35662363", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00408-022-00542-1" } }, { "@type": "ScholarlyArticle", "name": "Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36773509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.resinv.2023.01.003" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques respiratoires et circulatoires", "item": "https://questionsmedicales.fr/mesh/D002943" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiologiques respiratoires", "item": "https://questionsmedicales.fr/mesh/D012143" }, { "@type": "ListItem", "position": 4, "name": "Capacité pulmonaire totale", "item": "https://questionsmedicales.fr/mesh/D014109" }, { "@type": "ListItem", "position": 5, "name": "Capacité vitale", "item": "https://questionsmedicales.fr/mesh/D014797" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Capacité vitale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Capacité vitale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Capacité vitale", "description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Capacité vitale", "description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Capacité vitale", "description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Capacité vitale", "description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Capacité vitale", "description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Capacité vitale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?", "url": "https://questionsmedicales.fr/mesh/D014797#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la capacité vitale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels tests complètent l'évaluation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés." } }, { "@type": "Question", "name": "Quels sont les critères normaux de capacité vitale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L." } }, { "@type": "Question", "name": "Quand suspecter une capacité vitale réduite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires." } }, { "@type": "Question", "name": "Quels signes indiquent un problème pulmonaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une capacité vitale faible ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique." } }, { "@type": "Question", "name": "La toux est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée." } }, { "@type": "Question", "name": "Comment la fatigue se manifeste-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir la réduction de la capacité vitale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice physique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale." } }, { "@type": "Question", "name": "Faut-il éviter certaines expositions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire." } }, { "@type": "Question", "name": "L'hydratation est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires." } }, { "@type": "Question", "name": "Quels traitements améliorent la capacité vitale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes." } }, { "@type": "Question", "name": "La physiothérapie est-elle utile ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la cause ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires." } }, { "@type": "Question", "name": "La capacité vitale faible augmente-t-elle les risques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves." } }, { "@type": "Question", "name": "Les maladies cardiaques sont-elles liées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques." } }, { "@type": "Question", "name": "Comment les infections affectent-elles la capacité vitale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il la capacité vitale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Les maladies chroniques sont-elles un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne." } }, { "@type": "Question", "name": "L'environnement de travail est-il un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 16/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Toby M Maher

3 publications dans cette catégorie

Affiliations :
  • Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Imperial College London, London, UK.

Hyun Lee

3 publications dans cette catégorie

Affiliations :
  • Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.

Hye Yun Park

3 publications dans cette catégorie

Affiliations :
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Masato Kono

3 publications dans cette catégorie

Affiliations :
  • Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp.

Takafumi Suda

3 publications dans cette catégorie

Affiliations :
  • Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hidenori Nakamura

3 publications dans cette catégorie

Affiliations :
  • Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Nirav R Bhakta

2 publications dans cette catégorie

Affiliations :
  • University of California San Francisco, 8785, San Francisco, California, United States.
Publications dans "Capacité vitale" :

Ivan Bautmans

2 publications dans cette catégorie

Affiliations :
  • Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium; Department of Geriatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: ivan.bautmans@vub.be.

Veerle Knoop

2 publications dans cette catégorie

Affiliations :
  • Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium.

Jotheeswaran Amuthavalli Thiyagarajan

2 publications dans cette catégorie

Affiliations :
  • Ageing and Health Unit, WHO, Geneva, Switzerland.

Andrea B Maier

2 publications dans cette catégorie

Affiliations :
  • Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, Australia; Yong Loo Lin School of Medicine, Centre for Healthy Longevity, National University of Singapore, Singapore; National University Health System, Singapore.

Ellen Freiberger

2 publications dans cette catégorie

Affiliations :
  • Institute for Biomedicine of Aging, University of Erlangen-Nuremberg, Nuremberg, Germany.

Mylene Aubertin-Leheudre

2 publications dans cette catégorie

Affiliations :
  • Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Faculty of Sciences, Department of Exercise Sciences, Université du Québec à Montréal, QC, Canada.

Martin Kolb

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.

Susanne Stowasser

2 publications dans cette catégorie

Affiliations :
  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.

Michael Kreuter

2 publications dans cette catégorie

Affiliations :
  • Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.

Fernando J Martinez

2 publications dans cette catégorie

Affiliations :
  • Weill Cornell Medicine, New York, New York, USA.

M Bradley Drummond

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.

Kwang Ha Yoo

2 publications dans cette catégorie

Affiliations :
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.

Sources (8578 au total)

Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease.

Fibrotic interstitial lung disease (ILD) includes a large group of conditions that lead to scarring of the lungs. The lack of available 5-level EuroQol 5D (EQ5D) data has limited the ability to conduc... EQ5D utility and pulmonary function measurements from the Canadian Registry for Pulmonary Fibrosis were included. Ordinary least squares (OLS), beta regression, two-part, and tobit models were used to... The OLS model performed as well as other more complex models (root mean squared error: 0.17 for FVC and 0.16 for DLCO). As with the other models, the OLS algorithm performed well across the different ... We developed a mapping algorithm that predicts EQ5D utilities from FVC and DLCO, with the intent that this algorithm can be applied to clinical trial populations and real-world cohorts that have not p...

Lung and chest wall volume during vital capacity manoeuvre in Osteogenesis Imperfecta.

Although Osteogenesis Imperfecta (OI) affects the connective tissue, pulmonary function might be compromised because of thoracic deformities. OI is known to be a restrictive lung disease, but spiromet... Type III patients were characterized by lower spirometric lung volume, by lower sleep quality, by a more compressed thoracic configuration aggravated by severe scoliosis, by reduced global expansion a... The kinematics of the trunk changed to compensate for the severe structural deformities by shifting the expansion in the abdomen both at rest and during maximal manoeuvre because of a restricted thora...

Body Mass Index is Associated with blood pressure and vital capacity in medical students.

The widely reported associations between body mass index (BMI) and various chronic diseases, such as hypertension and asthma, have garnered significant attention. Nonetheless, there remains a dearth o... This study included a cohort of 843 medical students enrolled at Southern Medical University who were selected through random cluster sampling. Within this cohort, measurements of height, weight, BP, ... Within the participant pool, 9.4% and 3.8% of participants were classified as overweight and obese, respectively. Additionally, the prevalence of prehypertension, hypertension, and poor VCI was 18.1%,... BMI demonstrated a notably strong positive correlation with both BP and vital capacity and a negative correlation with VCI. Therefore, for medical students as well as the daily health care of patients...

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations.

Forced vital capacity (FVC) is often preserved in severe asthma unless there is evidence of either airway remodelling or air trapping. Area under the reactance curve (AX) can be used to assess small a... We explore if there may be a potential synergistic interaction between FVC and AX in terms of impaired asthma control as ACQ and exacerbations requiring oral corticosteroids (OCS). We pragmatically de... Patients with combined impairment of FVC and AX had significantly worse asthma control as higher ACQ, more severe exacerbations requiring OCS and worse spirometry (FEV... This in turn supports using both spirometry and oscillometry to characterise airway physiology more comprehensively in patients with more severe asthma....

Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.

Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is heterogeneous, with some patients showing a progressive decline in forced vital capacity (FVC). However, the clinical features of these cases wit... This retrospective study included 48 patients diagnosed with IPPFE who underwent longitudinal pulmonary function tests at our institution from 2005 to 2021. The progressive phenotype was defined as a ... Of the 48 patients, 23 (47.9%) were classified as progressive IPPFE. They were significantly older with a higher rate of dyspnea, fine crackles on chest auscultation, lower-lobe usual interstitial pne... With a progressive decline in %FVC, IPPFE often has an advanced stage at diagnosis and lower-lobe UIP pattern and is associated with weight loss and worse survival....

Slow vital capacity as a useful indicator of the prognosis after percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis.

Forced vital capacity (FVC) is recommended as a respiratory function test in patients with amyotrophic lateral sclerosis (ALS). However, in ALS associated with orofacial palsy, FVC may be an unreliabl... We conducted this retrospective observational cohort study of 69 consecutive patients diagnosed with sporadic ALS who underwent PEG placement between July 2007 and February 2020. We analyzed the assoc... Forty-four patients met the inclusion criteria. In cases with decreased SVC (p < .01) and FVC (p < .01), a significant difference was observed in mortality 6 months after PEG placement, with an optima... SVC, like FVC, is an important prognostic factor after PEG placement in patients with ALS, and there is a possibility that evaluation using SVC can complement respiratory function testing even in case...

Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.

The clinical implication of bronchodilator response (BDR) is not fully understood. However, BDR is frequently present in patients with chronic obstructive pulmonary disease (COPD). We identified the d... We used data from the Korea COPD Subgroup Study, a multicenter cohort study of COPD patients recruited from 54 centers in South Korea since April 2012. We analyzed differences in baseline characterist... Of the 2,181 patients enrolled in this study, 366 (16.8%) were BDR positive. BDR positive patients were more likely to be ever-smokers and to have a lower body mass index and higher symptom scores com... In this study, BDR positive patients were more likely to be ever-smokers and to have worse symptoms and lung function than BDR negative patients. BDR-FVC was associated with worse symptom control and ...

Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort.

Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with a variable clinical trajectory. Decline in forced vital capacity (FVC) is the main indicator of progression; however, missingn... We did a secondary analysis of longitudinal data on FVC collected from a cohort of patients with idiopathic pulmonary fibrosis from the PROFILE study; a multicentre, prospective, observational cohort ... 415 (71%) of 581 participants recruited into the PROFILE study were eligible for further analysis. An unsupervised machine learning algorithm had the lowest imputation error among tested methods, and ... Using a data-driven unsupervised approach, we identified four clusters of lung function trajectory with distinct clinical and biochemical features. Enriching or stratifying longitudinal spirometric da... National Institute for Health and Care Research, Medical Research Council, and GlaxoSmithKline....

The associations between body composition and vital capacity index of medical students in Shenyang of China: a cross-sectional survey.

This study aimed to examine the associations between body composition and vital capacity index (VCI) among medical students of Shenyang, China.... The design of this study is a cross-sectional study.... Participants were 2063 individuals (17-25 years) from a medical college in Shenyang, who participated in this survey from April to May 2017. Height, weight, fat mass (FM), fat free mass (FFM), protein... Male students showed significantly higher height, weight, BMI, FFM, PM, TBW, MM, VC, and VCI, but lower FM in comparison with female students. Stepwise multiple linear regression analysis showed that ... Overall, FM is highly negatively correlated with the VCI of Chinese medical students of both genders. However, there was a positive correlation between FM and VCI among low-weight male students....

Respiratory function of children and adolescents with osteogenesis imperfecta: respiratory muscle strength, forced vital capacity, and peak expiratory flow.

This study aims to evaluate the respiratory function of children and adolescents with osteogenesis imperfecta (OI) followed up at a referral center.... A cross-sectional study was conducted with a non-probabilistic sample. Manovacuometry was performed with the measurement of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), an... In total, 23 individuals were evaluated, with a mean age of 11.6±3.4 years, 56.5% of whom were females. Regarding the classification of OI, 56.5% of the sample belonged to type IV, 30.5% to type III, ... Respiratory function of the study subjects was altered, with respiratory muscle strength values lower than expected in the whole sample, and peak expiratory flow was significantly reduced in the OI ty...